EUVIMEDEUVIMED entdecken
Crossref

Using Network Pharmacology and Transcriptome Sequencing to Investigate the Mechanism of Action of Luteolin and Quercetin in Treating Obesity

Ruoshuang Liu, Zhaoxiang Wang, Kangru Shi, Yirong Shen, Xiawen Yu, Caiqin Cheng, Yue Xia, Guoyu Dai, Zhicong Zhao, Yuyun Xiong, Dong Wang, Ling Yang und 2 weitere

Chemical Biology & Drug Design · 2025

DOI: 10.1111/cbdd.70061 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemical Biology & Drug Design, 2025. Verfasst von Ruoshuang Liu und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology and Metabolism, The Affiliated Hospital of Jiangsu University, Zhenjiang, Jiangsu, China. Hauptthemen laut MEDLINE: Quercetin, Luteolin, Obesity, Transcriptome. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 52 Literaturangaben. Gefördert von: Youth Medical Talent Project of Jiangsu Province, Science and Technology Commission of Zhenjiang City, Doctoral Research Initiation Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Luteolin and quercetin, which are flavonoids, are present in various traditional Chinese medicines. Although they have been shown to improve obesity, the specific mechanisms of action remain unclear. This study aimed to determine pivotal targets and major regulatory pathways involved in their mechanisms of action using network pharmacology and transcriptome sequencing. Data on luteolin/quercetin‐related targets were acquired from the PharmMapper platform, and data on known obesity‐related targets were collected from the OMIM and GeneCards databases. Differentially expressed genes (DEGs) involved in luteolin and quercetin action that regulate adipogenic differentiation were identified using RNA sequencing (RNA‐seq). Bioinformatic analyses were performed to identify potential target genes and pathways regulated by luteolin/quercetin during adipogenesis. Finally, key genes and pathways were validated through quantitative real‐time polymerase chain reaction (qRT‐PCR) and Western blotting. Network pharmacology showed that luteolin/quercetin was closely associated with anti‐obesity targets. The related pathways were metabolic, PI3K/AKT, and MAPK pathways. RNA‐seq revealed 91 common DEGs involved in luteolin/quercetin regulation of adipogenic differentiation. Finally, nine potential target genes (including CIDEC, Mgll, Slc2a4, Pck1, and PNPLA3) were identified, and the AMPK and AKT signaling pathways were verified. The present study provides novel information regarding the molecular mechanism of luteolin and quercetin action in treating obesity and demonstrates their therapeutic effects through multiple targets and pathways.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

QuercetinLuteolinObesityTranscriptomeNetwork PharmacologyAdipogenesisAnimalsMice3T3-L1 CellsSignal TransductionHumansAnti-Obesity Agents

Stichwörter der Autor:innen

luteolinnetwork pharmacologyobesityquercetintranscriptome sequencing

Substanzen

QuercetinLuteolinAnti-Obesity Agents

Autor:innen und Institutionen

  • Department of Endocrinology and Metabolism, The Affiliated Hospital of Jiangsu University, Zhenjiang, Jiangsu, China.
  • Department of Clinical Laboratory, The Affiliated Hospital of Jiangsu University, Zhenjiang, Jiangsu, China.

Förderung

  • Youth Medical Talent Project of Jiangsu Province
  • Science and Technology Commission of Zhenjiang City
  • Doctoral Research Initiation Fund
  • Clinical Medical Science and Technology Development Foundation of Jiangsu University
  • Key Project for Medical Education Collaborative Innovation Fund of Jiangsu University
  • Open Project of Clinical Medical Research Center of Gynecology and Traditional Chinese Medicine of Zhenjiang

Zitieren

APA

Liu, R., Wang, Z., Shi, K., Shen, Y., Yu, X., Cheng, C., Xia, Y., Dai, G., Zhao, Z., Xiong, Y., Wang, D., Yang, L., Yuan, G., & Jia, J. (2025). Using Network Pharmacology and Transcriptome Sequencing to Investigate the Mechanism of Action of Luteolin and Quercetin in Treating Obesity. Chemical Biology & Drug Design. https://doi.org/10.1111/cbdd.70061

Vancouver

Liu R, Wang Z, Shi K, Shen Y, Yu X, Cheng C, et al. Using Network Pharmacology and Transcriptome Sequencing to Investigate the Mechanism of Action of Luteolin and Quercetin in Treating Obesity. Chemical Biology & Drug Design. 2025. doi:10.1111/cbdd.70061

BibTeX
@article{Liu2025,
  author = {Liu, Ruoshuang and Wang, Zhaoxiang and Shi, Kangru and Shen, Yirong and Yu, Xiawen and Cheng, Caiqin and Xia, Yue and Dai, Guoyu and Zhao, Zhicong and Xiong, Yuyun and Wang, Dong and Yang, Ling and Yuan, Guoyue and Jia, Jue},
  title = {Using Network Pharmacology and Transcriptome Sequencing to Investigate the Mechanism of Action of Luteolin and Quercetin in Treating Obesity},
  journal = {Chemical Biology & Drug Design},
  year = {2025},
  doi = {10.1111/cbdd.70061}
}
Kostenlos starten →